|
Elizabeth Andrews, PhD and MPH, is currently the vice president of Pharmacoepidemiology and Risk Management at RTI Health Solutions, a business unit of RTI International, which she joined in 2001. Dr. Andrews provides consultation to pharmaceutical companies and the U.S. Food and Drug Administration on epidemiology and therapeutic risk management and directs research programs that evaluate drug safety and compliance with prescribing and treatment guidelines. While her experience has spanned most therapeutic areas, she has worked extensively in the areas of HIV, sexually transmitted diseases, birth defects and neonatal health, and irritable bowel syndrome. Dr. Andrews has 18 years of experience working within the pharmaceutical industry, where she most recently served as the vice president of Worldwide Epidemiology at GlaxoSmithKline. She is a fellow and past president of the International Society for Pharmacoepidemiology and a member of the editorial board of the Journal of Pharmacoepidemiology and Drug Safety. | 